Display options
Share it on

Contraception. 2018 Apr 07; doi: 10.1016/j.contraception.2018.03.035. Epub 2018 Apr 07.

Can inhibition of retinoic acid biosynthesis function as a non-hormonal female contraceptive?.

Contraception

Jisun Paik, Piper M Treuting, Michael Haenisch, John K Amory

Affiliations

  1. Department of Comparative Medicine, University of Washington, Seattle, WA, USA. Electronic address: [email protected].
  2. Department of Comparative Medicine, University of Washington, Seattle, WA, USA.
  3. Department of Medicine, University of Washington, Seattle, WA, USA.

PMID: 29630869 PMCID: PMC6174106 DOI: 10.1016/j.contraception.2018.03.035

Abstract

OBJECTIVE: Vitamin A deficient females have reduced fertility due to decreased retinoic acid production. WIN 18,446 inhibits retinoic acid biosynthesis and functions as a contraceptive in males. We tested whether WIN 18,446 treatment would suppress fertility in female mice.

STUDY DESIGN: Female mice were treated with WIN 18,446 and mated. Pregnancy rates were compared using Fisher's exact test.

RESULTS: WIN 18,446 reduced pregnancy compared with control (p=.03). However, one animal became pregnant with malformed embryos.

CONCLUSIONS: WIN 18,446 treatment significantly reduces fecundity, but teratogenicity in the setting of contraceptive failure limits the appeal of this approach to female contraception.

Copyright © 2018 Elsevier Inc. All rights reserved.

Keywords: aldehyde dehydrogenase 1A; enzyme inhibitor; pregnancy; retinoic acid

References

  1. J Androl. 2011 Jan-Feb;32(1):111-9 - PubMed
  2. Am J Obstet Gynecol. 1974 Jul 1;119(5):583-8 - PubMed
  3. Annu Rev Nutr. 2002;22:347-81 - PubMed
  4. Biol Reprod. 2016 Sep;95(3):70 - PubMed
  5. Hum Reprod. 2010 Oct;25(10):2579-90 - PubMed
  6. J Biol Chem. 2014 May 23;289(21):15104-17 - PubMed
  7. Endocrinology. 2016 May;157(5):2160-72 - PubMed
  8. Cell. 1995 Dec 15;83(6):859-69 - PubMed
  9. Teratology. 1978 Aug;18(1):5-15 - PubMed

Publication Types

Grant support